Page last updated: 2024-08-25

methotrexate and Carcinoma, Medullary

methotrexate has been researched along with Carcinoma, Medullary in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hibshoosh, H; Noguera-Irizarry, WG; Papadopoulos, KP	1
Bünemann, H; Heilmann, HP; Janik, I; Willers, H; Würschmidt, F	1
Abraham, J; Barrett-Lee, P; Faris, M	1

Reviews

1 review(s) available for methotrexate and Carcinoma, Medullary

Article	Year
Renal medullary carcinoma: case report and review of the literature. American journal of clinical oncology, 2003, Volume: 26, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Medullary; Cisplatin; Doxorubicin; Fatal Outcome; Female; Hispanic or Latino; Humans; Kidney Neoplasms; Methotrexate; Vinblastine	2003

Other Studies

2 other study(ies) available for methotrexate and Carcinoma, Medullary

Article	Year
[Combined breast-preserving surgery, chemotherapy and radiotherapy in the treatment of breast carcinoma. Effect of the interval between surgery and the beginning of radiotherapy]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1997, Volume: 173, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiotherapy Dosage; Retrospective Studies; Time Factors	1997
A patient with breast cancer and paraneoplastic cerebellar syndrome associated with anti-Purkinje cell antibodies: response to CMF chemotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:3 Topics: Adult; Antibodies; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Medullary; Cerebellar Ataxia; Cyclophosphamide; Female; Fluorouracil; Humans; Immunosuppressive Agents; Methotrexate; Ovary; Paraneoplastic Syndromes; Purkinje Cells	1998

Article

Year

[Combined breast-preserving surgery, chemotherapy and radiotherapy in the treatment of breast carcinoma. Effect of the interval between surgery and the beginning of radiotherapy].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1997, Volume: 173, Issue:3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiotherapy Dosage; Retrospective Studies; Time Factors

1997

A patient with breast cancer and paraneoplastic cerebellar syndrome associated with anti-Purkinje cell antibodies: response to CMF chemotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:3

Topics: Adult; Antibodies; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Medullary; Cerebellar Ataxia; Cyclophosphamide; Female; Fluorouracil; Humans; Immunosuppressive Agents; Methotrexate; Ovary; Paraneoplastic Syndromes; Purkinje Cells

1998